Astera Labs (NASDAQ:ALAB) Shares Up 11.2% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price shot up 11.2% on Tuesday . The company traded as high as $333.43 and last traded at $355.8730. 5,536,685 shares were traded during trading, a decline of 11% from the average session volume of 6,195,268 shares. The stock had previously closed at $320.09.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ALAB. Stifel Nicolaus increased their price target on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Susquehanna increased their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Barclays increased their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Finally, Evercore reiterated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Trading Up 2.2%

The stock has a market capitalization of $62.31 billion, a price-to-earnings ratio of 245.64, a PEG ratio of 4.71 and a beta of 3.95. The firm has a 50-day moving average of $204.28 and a 200 day moving average of $169.07.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm earned $0.33 EPS. The firm’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. This represents a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,298,757 shares of company stock worth $472,787,436 in the last three months. 10.40% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Several large investors have recently added to or reduced their stakes in the business. Glenmede Trust Co. NA increased its position in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the period. Verus Capital Partners LLC increased its position in shares of Astera Labs by 16.4% during the 1st quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after purchasing an additional 541 shares during the period. Liontrust Investment Partners LLP increased its position in shares of Astera Labs by 98.7% during the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock valued at $11,538,000 after purchasing an additional 52,284 shares during the period. SOA Wealth Advisors LLC. acquired a new position in shares of Astera Labs during the 1st quarter valued at $49,000. Finally, E20 Capital Ltd acquired a new position in shares of Astera Labs during the 1st quarter valued at $33,310,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.